| Symbol |
Name |
Standardized Value |
|
TAC1
|
tachykinin, precursor 1
|
3.121
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
2.838
|
|
COMT
|
catechol-O-methyltransferase
|
2.793
|
|
IL6
|
interleukin 6
|
2.761
|
|
OPRM1
|
opioid receptor, mu 1
|
2.742
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.727
|
|
ASIC3
|
acid sensing (proton gated) ion channel 3
|
2.726
|
|
TNF
|
tumor necrosis factor
|
2.704
|
|
BDNF
|
brain-derived neurotrophic factor
|
2.675
|
|
IL1B
|
interleukin 1, beta
|
2.674
|
|
LAPTM4A
|
lysosomal protein transmembrane 4 alpha
|
2.642
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
2.619
|
|
POMC
|
proopiomelanocortin
|
2.567
|
|
CRH
|
corticotropin releasing hormone
|
2.564
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
2.547
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
2.521
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
2.457
|
|
IL10
|
interleukin 10
|
2.422
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
2.401
|
|
MAOA
|
monoamine oxidase A
|
2.382
|
|
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing
|
2.35
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
2.295
|
|
MAOB
|
monoamine oxidase B
|
2.28
|
|
KNG1
|
kininogen 1
|
2.267
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
2.259
|
|
IL1A
|
interleukin 1, alpha
|
2.25
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
2.207
|
|
FMR1
|
fragile X mental retardation 1
|
2.191
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
2.178
|
|
IL17A
|
interleukin 17A
|
2.176
|
|
TACR1
|
tachykinin receptor 1
|
2.17
|
|
IFNG
|
interferon, gamma
|
2.13
|
|
P2RX3
|
purinergic receptor P2X, ligand gated ion channel, 3
|
2.128
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
2.121
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
2.116
|
|
TSPO
|
translocator protein (18kDa)
|
2.116
|
|
PDYN
|
prodynorphin
|
2.113
|
|
TLR4
|
toll-like receptor 4
|
2.086
|
|
IL4
|
interleukin 4
|
2.083
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
2.079
|
|
SCN11A
|
sodium channel, voltage gated, type XI alpha subunit
|
2.078
|
|
NPY
|
neuropeptide Y
|
2.066
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
2.062
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
2.051
|
|
INS
|
insulin
|
2.035
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
2.03
|
|
FAAH
|
fatty acid amide hydrolase
|
2.015
|
|
IL2
|
interleukin 2
|
2.012
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
2.003
|
|
LEP
|
leptin
|
2.001
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
1.987
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
1.975
|
|
HTR3B
|
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic
|
1.974
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
1.963
|
|
IL18
|
interleukin 18
|
1.962
|
|
KCNS1
|
potassium voltage-gated channel, modifier subfamily S, member 1
|
1.957
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
1.953
|
|
PNOC
|
prepronociceptin
|
1.948
|
|
CKM
|
creatine kinase, muscle
|
1.923
|
|
LIPN
|
lipase, family member N
|
1.922
|
|
CKB
|
creatine kinase, brain
|
1.92
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
1.912
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.909
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.908
|
|
CD4
|
CD4 molecule
|
1.907
|
|
GPSM2
|
G-protein signaling modulator 2
|
1.885
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.884
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.883
|
|
ATPSCKMT
|
ATP synthase c subunit lysine N-methyltransferase
|
1.881
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
1.867
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
1.847
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
1.84
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
1.837
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.837
|
|
PRTN3
|
proteinase 3
|
1.836
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
1.82
|
|
ALB
|
albumin
|
1.82
|
|
OSTF1
|
osteoclast stimulating factor 1
|
1.817
|
|
ACE
|
angiotensin I converting enzyme
|
1.813
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
1.801
|
|
PENK
|
proenkephalin
|
1.798
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
1.797
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
1.796
|
|
GPR55
|
G protein-coupled receptor 55
|
1.794
|
|
IL13
|
interleukin 13
|
1.792
|
|
ASIC2
|
acid sensing (proton gated) ion channel 2
|
1.778
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
1.776
|
|
TAAR1
|
trace amine associated receptor 1
|
1.775
|
|
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit
|
1.771
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
1.764
|
|
ANK1
|
ankyrin 1, erythrocytic
|
1.752
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
1.745
|
|
DRD2
|
dopamine receptor D2
|
1.745
|
|
PRL
|
prolactin
|
1.743
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.743
|
|
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3
|
1.743
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
1.742
|
|
AIF1
|
allograft inflammatory factor 1
|
1.735
|
|
TRIM21
|
tripartite motif containing 21
|
1.726
|
|
OPRD1
|
opioid receptor, delta 1
|
1.704
|
|
IFNA1
|
interferon, alpha 1
|
1.703
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
1.699
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.698
|
|
IL5
|
interleukin 5
|
1.693
|
|
MYT1L
|
myelin transcription factor 1-like
|
1.688
|
|
PTH
|
parathyroid hormone
|
1.682
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
1.681
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.68
|
|
SCN3A
|
sodium channel, voltage gated, type III alpha subunit
|
1.677
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.677
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
1.675
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
1.669
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
1.667
|
|
CD8A
|
CD8a molecule
|
1.664
|
|
GDNF
|
glial cell derived neurotrophic factor
|
1.655
|
|
SST
|
somatostatin
|
1.645
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
1.644
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.643
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
1.637
|
|
HTR3C
|
5-hydroxytryptamine (serotonin) receptor 3C, ionotropic
|
1.633
|
|
HTR1D
|
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
|
1.628
|
|
NAA60
|
N(alpha)-acetyltransferase 60, NatF catalytic subunit
|
1.626
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
1.623
|
|
AMY1B
|
amylase, alpha 1B (salivary)
|
1.623
|
|
CREB1
|
cAMP responsive element binding protein 1
|
1.617
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
1.609
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
1.609
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.606
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
1.605
|
|
PIEZO2
|
piezo-type mechanosensitive ion channel component 2
|
1.6
|
|
DRD4
|
dopamine receptor D4
|
1.599
|
|
GAL
|
galanin/GMAP prepropeptide
|
1.597
|
|
VIP
|
vasoactive intestinal peptide
|
1.582
|
|
ASIC4
|
acid sensing (proton gated) ion channel family member 4
|
1.574
|
|
TH
|
tyrosine hydroxylase
|
1.572
|
|
HTR3E
|
5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
|
1.571
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
1.57
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
1.569
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
1.567
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
1.564
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
1.563
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.561
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.557
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
1.556
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
1.55
|
|
S100B
|
S100 calcium binding protein B
|
1.543
|
|
TLR2
|
toll-like receptor 2
|
1.54
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
1.538
|
|
GPX5
|
glutathione peroxidase 5
|
1.533
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
1.533
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
1.533
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
1.531
|
|
ESR1
|
estrogen receptor 1
|
1.527
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.527
|
|
TRIM32
|
tripartite motif containing 32
|
1.526
|
|
MGLL
|
monoglyceride lipase
|
1.525
|
|
GPX6
|
glutathione peroxidase 6
|
1.525
|
|
GPR18
|
G protein-coupled receptor 18
|
1.524
|
|
GPX8
|
glutathione peroxidase 8 (putative)
|
1.523
|
|
GPX7
|
glutathione peroxidase 7
|
1.52
|
|
GPX2
|
glutathione peroxidase 2
|
1.52
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.517
|
|
TGM2
|
transglutaminase 2
|
1.509
|
|
NRXN3
|
neurexin 3
|
1.508
|
|
GPX3
|
glutathione peroxidase 3
|
1.506
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
1.503
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
1.502
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
1.501
|
|
FKBP5
|
FK506 binding protein 5
|
1.498
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
1.494
|
|
CPZ
|
carboxypeptidase Z
|
1.493
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.49
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.489
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
1.485
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.482
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
1.477
|
|
POLI
|
polymerase (DNA directed) iota
|
1.469
|
|
METTL18
|
methyltransferase like 18
|
1.468
|
|
OGFR
|
opioid growth factor receptor
|
1.468
|
|
MMP3
|
matrix metallopeptidase 3
|
1.465
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1.464
|
|
NAPEPLD
|
N-acyl phosphatidylethanolamine phospholipase D
|
1.464
|
|
CCK
|
cholecystokinin
|
1.458
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
1.458
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
1.456
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
1.455
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.453
|
|
HP
|
haptoglobin
|
1.451
|
|
MMP9
|
matrix metallopeptidase 9
|
1.448
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
1.448
|
|
REN
|
renin
|
1.432
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
1.43
|
|
DRD3
|
dopamine receptor D3
|
1.429
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
1.428
|
|
GFAP
|
glial fibrillary acidic protein
|
1.427
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
1.424
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
1.421
|
|
MEFV
|
Mediterranean fever
|
1.418
|
|
LTA
|
lymphotoxin alpha
|
1.417
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
1.414
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1.413
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.408
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
1.407
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.406
|
|
JUN
|
jun proto-oncogene
|
1.405
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
1.404
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
1.4
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
1.397
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
1.396
|
|
IFNA2
|
interferon, alpha 2
|
1.396
|
|
CACNA1I
|
calcium channel, voltage-dependent, T type, alpha 1I subunit
|
1.394
|
|
IL15
|
interleukin 15
|
1.392
|
|
PXDNL
|
peroxidasin-like
|
1.391
|
|
C3
|
complement component 3
|
1.39
|
|
PXDN
|
peroxidasin
|
1.39
|
|
ARTN
|
artemin
|
1.389
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
1.388
|
|
OGN
|
osteoglycin
|
1.387
|
|
TPO
|
thyroid peroxidase
|
1.386
|
|
CALCB
|
calcitonin-related polypeptide beta
|
1.385
|
|
IL7
|
interleukin 7
|
1.384
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.382
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
1.382
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
1.38
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
1.379
|
|
EDN1
|
endothelin 1
|
1.377
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1.376
|
|
IFNA17
|
interferon, alpha 17
|
1.375
|
|
IFNA5
|
interferon, alpha 5
|
1.374
|
|
APP
|
amyloid beta (A4) precursor protein
|
1.371
|
|
IFNA14
|
interferon, alpha 14
|
1.369
|
|
GCH1
|
GTP cyclohydrolase 1
|
1.369
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.369
|
|
IFNA6
|
interferon, alpha 6
|
1.368
|
|
TPH1
|
tryptophan hydroxylase 1
|
1.367
|
|
DAGLA
|
diacylglycerol lipase, alpha
|
1.366
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.364
|
|
IFNA16
|
interferon, alpha 16
|
1.363
|
|
IFNA21
|
interferon, alpha 21
|
1.362
|
|
IFNA10
|
interferon, alpha 10
|
1.362
|
|
IFNA7
|
interferon, alpha 7
|
1.362
|
|
IFNA8
|
interferon, alpha 8
|
1.361
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
1.361
|
|
IFNA13
|
interferon, alpha 13
|
1.359
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.357
|
|
IFNA4
|
interferon, alpha 4
|
1.357
|
|
GRIA4
|
glutamate receptor, ionotropic, AMPA 4
|
1.357
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.357
|
|
MB
|
myoglobin
|
1.354
|
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18
|
1.353
|
|
TNXB
|
tenascin XB
|
1.35
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
1.346
|
|
HTR3D
|
5-hydroxytryptamine (serotonin) receptor 3D, ionotropic
|
1.345
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.345
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
1.344
|
|
AANAT
|
aralkylamine N-acetyltransferase
|
1.34
|
|
IL22
|
interleukin 22
|
1.338
|
|
ACTB
|
actin, beta
|
1.338
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
1.336
|
|
RETN
|
resistin
|
1.336
|
|
TRAM1L1
|
translocation associated membrane protein 1-like 1
|
1.335
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.335
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
1.334
|
|
RGS4
|
regulator of G-protein signaling 4
|
1.333
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
1.332
|
|
CNBP
|
CCHC-type zinc finger, nucleic acid binding protein
|
1.328
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
1.326
|
|
HMGB1
|
high mobility group box 1
|
1.326
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
1.326
|
|
CALCRL
|
calcitonin receptor-like
|
1.325
|
|
IL33
|
interleukin 33
|
1.323
|
|
OXTR
|
oxytocin receptor
|
1.318
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
1.315
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.314
|
|
RETNLB
|
resistin like beta
|
1.314
|
|
GPR119
|
G protein-coupled receptor 119
|
1.312
|
|
TALDO1
|
transaldolase 1
|
1.311
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
1.307
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
1.307
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.307
|
|
APOE
|
apolipoprotein E
|
1.307
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
1.305
|
|
TLR7
|
toll-like receptor 7
|
1.303
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.298
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.291
|
|
GHRH
|
growth hormone releasing hormone
|
1.29
|
|
CALML3
|
calmodulin-like 3
|
1.289
|
|
COQ9
|
coenzyme Q9
|
1.288
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
1.288
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
1.287
|
|
GH1
|
growth hormone 1
|
1.287
|
|
CCT5
|
chaperonin containing TCP1, subunit 5 (epsilon)
|
1.284
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
1.283
|
|
HRH1
|
histamine receptor H1
|
1.282
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
1.28
|
|
NGFR
|
nerve growth factor receptor
|
1.278
|
|
NTF3
|
neurotrophin 3
|
1.277
|
|
MPO
|
myeloperoxidase
|
1.276
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
1.276
|
|
CALML4
|
calmodulin-like 4
|
1.275
|
|
TG
|
thyroglobulin
|
1.274
|
|
CALML6
|
calmodulin-like 6
|
1.274
|
|
CALML5
|
calmodulin-like 5
|
1.272
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
1.269
|
|
IL37
|
interleukin 37
|
1.269
|
|
NTS
|
neurotensin
|
1.267
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
1.266
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
1.265
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
1.263
|
|
KCNK18
|
potassium channel, two pore domain subfamily K, member 18
|
1.263
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.263
|
|
AOC1
|
amine oxidase, copper containing 1
|
1.263
|
|
TDO2
|
tryptophan 2,3-dioxygenase
|
1.261
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.26
|
|
AMIGO3
|
adhesion molecule with Ig-like domain 3
|
1.258
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
1.257
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
1.252
|
|
ARRB2
|
arrestin, beta 2
|
1.25
|
|
NPS
|
neuropeptide S
|
1.25
|
|
DAGLB
|
diacylglycerol lipase, beta
|
1.249
|
|
ADRB1
|
adrenoceptor beta 1
|
1.249
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
1.241
|
|
IL9
|
interleukin 9
|
1.241
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
1.24
|
|
OPN4
|
opsin 4
|
1.239
|
|
NAV1
|
neuron navigator 1
|
1.239
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
1.236
|
|
PVALB
|
parvalbumin
|
1.236
|
|
RBFOX3
|
RNA binding protein, fox-1 homolog (C. elegans) 3
|
1.236
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
1.233
|
|
FOXP3
|
forkhead box P3
|
1.231
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
1.23
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
1.228
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
1.227
|
|
PDSS1
|
prenyl (decaprenyl) diphosphate synthase, subunit 1
|
1.225
|
|
MAPT
|
microtubule-associated protein tau
|
1.225
|
|
AVP
|
arginine vasopressin
|
1.223
|
|
IL31
|
interleukin 31
|
1.221
|
|
NAAA
|
N-acylethanolamine acid amidase
|
1.219
|
|
PRKCG
|
protein kinase C, gamma
|
1.218
|
|
BCHE
|
butyrylcholinesterase
|
1.215
|
|
AMY2B
|
amylase, alpha 2B (pancreatic)
|
1.212
|
|
CACNA1F
|
calcium channel, voltage-dependent, L type, alpha 1F subunit
|
1.212
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
1.207
|
|
ADRB3
|
adrenoceptor beta 3
|
1.206
|
|
ZNF77
|
zinc finger protein 77
|
1.205
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.205
|
|
ASMT
|
acetylserotonin O-methyltransferase
|
1.204
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
1.204
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.203
|
|
KCNJ6
|
potassium channel, inwardly rectifying subfamily J, member 6
|
1.201
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.201
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.201
|
|
AGBL2
|
ATP/GTP binding protein-like 2
|
1.199
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.196
|
|
GC
|
group-specific component (vitamin D binding protein)
|
1.196
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.196
|
|
EXD3
|
exonuclease 3'-5' domain containing 3
|
1.196
|
|
CA6
|
carbonic anhydrase VI
|
1.195
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
1.194
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
1.194
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
1.193
|
|
EDNRA
|
endothelin receptor type A
|
1.192
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.188
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
1.183
|
|
SP9
|
Sp9 transcription factor
|
1.183
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.183
|
|
ATF3
|
activating transcription factor 3
|
1.183
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
1.181
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.181
|
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
|
1.179
|
|
SIRT1
|
sirtuin 1
|
1.179
|
|
SLC17A6
|
solute carrier family 17 (vesicular glutamate transporter), member 6
|
1.179
|
|
TLR3
|
toll-like receptor 3
|
1.177
|
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
1.177
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
1.175
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
1.173
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.172
|
|
AMY2A
|
amylase, alpha 2A (pancreatic)
|
1.172
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
1.172
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
1.171
|
|
ACAN
|
aggrecan
|
1.168
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.168
|
|
NTF4
|
neurotrophin 4
|
1.167
|
|
TAAR2
|
trace amine associated receptor 2
|
1.166
|
|
MBP
|
myelin basic protein
|
1.166
|
|
KRT76
|
keratin 76, type II
|
1.163
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
1.162
|
|
RNF123
|
ring finger protein 123
|
1.162
|
|
GAD1
|
glutamate decarboxylase 1 (brain, 67kDa)
|
1.161
|
|
STAMBP
|
STAM binding protein
|
1.161
|
|
TRH
|
thyrotropin-releasing hormone
|
1.159
|
|
NPR3
|
natriuretic peptide receptor 3
|
1.155
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
1.155
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
1.155
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
1.152
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
1.149
|
|
KCNA2
|
potassium channel, voltage gated shaker related subfamily A, member 2
|
1.149
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
1.148
|
|
PIR
|
pirin (iron-binding nuclear protein)
|
1.147
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
1.146
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
1.146
|
|
CD68
|
CD68 molecule
|
1.146
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
1.146
|
|
EGF
|
epidermal growth factor
|
1.144
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
1.141
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
1.141
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
1.141
|
|
COQ8A
|
coenzyme Q8A
|
1.141
|
|
GSR
|
glutathione reductase
|
1.139
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
1.138
|
|
CMA1
|
chymase 1, mast cell
|
1.138
|
|
COQ2
|
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase
|
1.137
|
|
TPH2
|
tryptophan hydroxylase 2
|
1.137
|
|
ASIC5
|
acid sensing (proton gated) ion channel family member 5
|
1.136
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
1.134
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
1.129
|
|
CTSS
|
cathepsin S
|
1.128
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.128
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.128
|
|
JAK2
|
Janus kinase 2
|
1.128
|
|
RAD51B
|
RAD51 paralog B
|
1.125
|
|
CD19
|
CD19 molecule
|
1.125
|
|
IL17F
|
interleukin 17F
|
1.125
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
1.124
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
1.123
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
1.123
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
1.123
|
|
GH2
|
growth hormone 2
|
1.122
|
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7
|
1.122
|
|
IL16
|
interleukin 16
|
1.122
|
|
HSPA4
|
heat shock 70kDa protein 4
|
1.121
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
1.116
|
|
HCN2
|
hyperpolarization activated cyclic nucleotide gated potassium channel 2
|
1.114
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
1.114
|
|
MECP2
|
methyl CpG binding protein 2
|
1.114
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
1.111
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
1.11
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
1.109
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
1.106
|
|
OCLN
|
occludin
|
1.105
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.104
|
|
CAV3
|
caveolin 3
|
1.1
|
|
COQ7
|
coenzyme Q7 homolog, ubiquinone (yeast)
|
1.096
|
|
ORM2
|
orosomucoid 2
|
1.095
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
1.094
|
|
CLPB
|
ClpB homolog, mitochondrial AAA ATPase chaperonin
|
1.093
|
|
GPR32
|
G protein-coupled receptor 32
|
1.093
|
|
PREP
|
prolyl endopeptidase
|
1.093
|
|
GLUL
|
glutamate-ammonia ligase
|
1.091
|
|
IRF5
|
interferon regulatory factor 5
|
1.09
|
|
LTF
|
lactotransferrin
|
1.09
|
|
FN1
|
fibronectin 1
|
1.09
|
|
ARRB1
|
arrestin, beta 1
|
1.089
|
|
CYCS
|
cytochrome c, somatic
|
1.088
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
1.086
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
1.086
|
|
PIEZO1
|
piezo-type mechanosensitive ion channel component 1
|
1.084
|
|
NPSR1
|
neuropeptide S receptor 1
|
1.082
|
|
TLR9
|
toll-like receptor 9
|
1.082
|
|
ACR
|
acrosin
|
1.081
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.079
|
|
GRIN2D
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D
|
1.078
|
|
COMP
|
cartilage oligomeric matrix protein
|
1.077
|
|
TAC3
|
tachykinin 3
|
1.076
|
|
COQ5
|
coenzyme Q5 homolog, methyltransferase (S. cerevisiae)
|
1.071
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
1.071
|
|
GCG
|
glucagon
|
1.069
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
1.069
|
|
HMOX1
|
heme oxygenase 1
|
1.068
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
1.068
|
|
XDH
|
xanthine dehydrogenase
|
1.067
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
1.066
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.065
|
|
DROSHA
|
drosha, ribonuclease type III
|
1.065
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
1.063
|
|
VGLL1
|
vestigial-like family member 1
|
1.062
|
|
UCN
|
urocortin
|
1.061
|
|
RIMS4
|
regulating synaptic membrane exocytosis 4
|
1.06
|
|
FGF3
|
fibroblast growth factor 3
|
1.06
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
1.059
|
|
F2
|
coagulation factor II (thrombin)
|
1.059
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
1.059
|
|
SLC35A2
|
solute carrier family 35 (UDP-galactose transporter), member A2
|
1.059
|
|
WDFY2
|
WD repeat and FYVE domain containing 2
|
1.059
|
|
PI15
|
peptidase inhibitor 15
|
1.058
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
1.058
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.057
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
1.057
|
|
COQ8B
|
coenzyme Q8B
|
1.054
|
|
COQ4
|
coenzyme Q4
|
1.051
|
|
COQ6
|
coenzyme Q6 monooxygenase
|
1.05
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
1.048
|
|
QRFPR
|
pyroglutamylated RFamide peptide receptor
|
1.047
|
|
CSH2
|
chorionic somatomammotropin hormone 2
|
1.045
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
1.045
|
|
RTN1
|
reticulon 1
|
1.044
|
|
PON1
|
paraoxonase 1
|
1.043
|
|
CNTNAP2
|
contactin associated protein-like 2
|
1.042
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
1.042
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
1.042
|
|
FGF7
|
fibroblast growth factor 7
|
1.041
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
1.04
|
|
PANX1
|
pannexin 1
|
1.039
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
1.039
|
|
IL3
|
interleukin 3
|
1.037
|
|
MSTN
|
myostatin
|
1.037
|
|
CREM
|
cAMP responsive element modulator
|
1.036
|
|
RPAIN
|
RPA interacting protein
|
1.036
|
|
DRD1
|
dopamine receptor D1
|
1.035
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
1.035
|
|
FKBP14
|
FK506 binding protein 14, 22 kDa
|
1.034
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.033
|
|
CBR1
|
carbonyl reductase 1
|
1.033
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
1.033
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
1.03
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.03
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
1.029
|
|
TLR5
|
toll-like receptor 5
|
1.029
|
|
TTR
|
transthyretin
|
1.027
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
1.026
|
|
PTX3
|
pentraxin 3, long
|
1.026
|
|
GRK2
|
G protein-coupled receptor kinase 2
|
1.026
|
|
MMP1
|
matrix metallopeptidase 1
|
1.025
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
1.025
|
|
FNDC5
|
fibronectin type III domain containing 5
|
1.023
|
|
PCSK1N
|
proprotein convertase subtilisin/kexin type 1 inhibitor
|
1.023
|
|
FGF5
|
fibroblast growth factor 5
|
1.022
|
|
HDAC4
|
histone deacetylase 4
|
1.021
|
|
JAK1
|
Janus kinase 1
|
1.02
|
|
REST
|
RE1-silencing transcription factor
|
1.02
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
1.019
|
|
IL17RA
|
interleukin 17 receptor A
|
1.018
|
|
TOR1B
|
torsin family 1, member B (torsin B)
|
1.016
|
|
EPO
|
erythropoietin
|
1.015
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
1.015
|
|
TACR2
|
tachykinin receptor 2
|
1.014
|
|
MMP13
|
matrix metallopeptidase 13
|
1.014
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
1.013
|
|
GPR4
|
G protein-coupled receptor 4
|
1.013
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
1.012
|
|
FGF18
|
fibroblast growth factor 18
|
1.011
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.009
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
1.008
|
|
ACRV1
|
acrosomal vesicle protein 1
|
1.008
|
|
KCNK10
|
potassium channel, two pore domain subfamily K, member 10
|
1.008
|
|
GPR171
|
G protein-coupled receptor 171
|
1.008
|
|
TLR1
|
toll-like receptor 1
|
1.008
|
|
MRGPRX2
|
MAS-related GPR, member X2
|
1.007
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
1.005
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
1.005
|
|
AHR
|
aryl hydrocarbon receptor
|
1.005
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
1.003
|
|
FGF9
|
fibroblast growth factor 9
|
1.002
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
1.001
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
1.0
|
|
MMP2
|
matrix metallopeptidase 2
|
1.0
|
|
ENO1
|
enolase 1, (alpha)
|
1.0
|
